Bristol Myers Sotyktu Approval Sends Ventyx Stock Soaring: Consider Buying Both [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
NoSystem images/E+ via Getty ImagesInvestment Thesis - 2 Different Companies, 2 Similar Drugs, 2 Very Different Investment OpportunitiesThere is an old saying that "a bird in the hand is worth 2 in the bush", which, when applied to investing, essentially meansthat you are better off making a single sure bet than 2 speculative ones.This sentiment helps to explain why, when given the option of investing in the US' sixth largest Pharmaceutical organization by market cap, Bristol Myers Squibb (NYSE:BMYNASDAQ:VTYXIt may sound odd to even compare these 2 opportunities but there is arguably a good reason for doing so. On September 9th, the Food and Drug Administration ("FDA")approvedIn 2 Phase 3 studies Deucravacatinib - which will be marketed and sold under the brand name Sotyktu - a once daily therapy, demonstrated superior efficacy to rival Pharma Amgen's (AMGNThe co-primary endpoints were the percentage of patients who achieved Psoriasis Area and Severity Index 75 ("PASI 75") and the per
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Home Depot Eyes $12.5 Billion Debt Package to Fund SRS Merger [BNN Bloomberg (Canada)]BNN Bloomberg
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMYPR Newswire
- Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- Overhaul Sets New Standard in OTR Compliance with Launch of CompliTrack [Yahoo! Finance]Yahoo! Finance
- Healis Therapeutics announces collaboration with Massachusetts General Hospital (MGH) and affiliates of Harvard Medical School to advance clinical-stage neuroscience research [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/2/24 - Beat
BMY
Sec Filings
- 3/18/24 - Form 8-K
- 3/18/24 - Form PRE
- 3/18/24 - Form 8-K
- BMY's page on the SEC website